EUCTR2004-001622-24-IE进行中（未招募）1 期
Phase III,multicentre,open-label,prospective randomised trial comparing Imatinib alone at 400mg versus 800mg daily versus Imatinib 400mg daily plus PEG Interferon-alpha with newly diagnosed chronic myeloid leukaemia - Spirit
ewcastle Hospital Trust0 个研究点目标入组 259 人开始时间: 2005年1月19日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 259
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Within 3 months of initial diagnosis of chronic myeloid leukaemia in chronic phase
- •Previously intreated with the exception of hydroxyurea and/or anagrelide
- •Cytogenetic confirmation of Philadelphia chromosome or variants of (9;22) translocations
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients with PH-negative,BCR-ABL positive disease are NOT eligible
研究者
相似试验
进行中（未招募）
1 期
Keeping RAASi treatment with optimal potassium controlHyperkalemia in patients with chronic kidney disease (CKD) and heart failure historyMedDRA version: 21.1Level: LLTClassification code 10020647Term: HyperkalemiaSystem Organ Class: 100000004861MedDRA version: 23.1Level: PTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 20.0Level: LLTClassification code 10019285Term: Heart failure, unspecifiedSystem Organ Class: 100000004849EUCTR2020-003229-47-ESInstituto de Investigación Sanitaria INCLIVA78
招募中
3 期
Phase III, multicentre, randomized, open clinical trial comparing treatment with allogenic mesenchymal cells against autologous mesenchymal cells and against active control with hyaluronic acid in patients with knee osteoarthritis.Knee osteoarthritis2024-514545-11-00Fundacion Instituto De Estudios De Ciencias De La Salud De Castilla Y Leon120
招募中
3 期
A clinical trial of Insulin Aspart Mix 30 with innovator NovoMix 30 in patients with Diabetes Mellitus.CTRI/2024/03/064135BioGenomics Limited
进行中（未招募）
3 期
Clinical trial/study for lung cancer patients with ROS1 positiveCTRI/2022/04/041861F HoffmannLa Roche Ltd
进行中（未招募）
不适用
Safety and immunogenicity of different dosing schedules of GlaxoSmithkline (GSK) Biologicals’ Herpes Zoster (HZ) vaccine in adults 50 years of age or older.Vaccination against HZ and its related complications in adults older than 50 yearsMedDRA version: 14.1Level: PTClassification code 10019974Term: Herpes zosterSystem Organ Class: 10021881 - Infections and infestationsEUCTR2012-004456-11-EEGlaxoSmithKline Biologicals354